NF-κB signaling represents a rapid and potent response to exogenous or endogenous insults and plays a central and pleiotropic role in shaping the outcome of inflammation, including regulating inflammasome activation and the efficacy of anti-cancer therapies. Here, NFKB1 is linked to cancer.